
Opinion|Videos|November 29, 2023
AI in Multiple Sclerosis: Expert Insights Into Limitations and Opportunities
Author(s)Michael Dwyer, PhD, Robert Zivadinov, MD, PhD
Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Fenebrutinib Hits Key Phase 3 Marks in Relapsing and Primary Progressive MS
2
FDA Clears Phase 2a Clinical Trial to Test JOTROL in Patients With Parkinson Disease
3
OnabotulinumtoxinA Fails to Meet Primary End Point in Phase 3 PRECLUDE Trial for Episodic Migraine
4
Doxecitine/Doxribitine Approval Redefines Care in Thymidine Kinase 2 Deficiency: Fabian Somers, PhD
5



































